New Zealand markets close in 23 minutes

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.88-0.02 (-0.29%)
At close: 4:00PM EDT
6.92 +0.04 (+0.58%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.90
Bid6.88 x 3000
Ask6.92 x 4000
Day's range6.86 - 7.06
52-week range3.50 - 24.90
Avg. volume5,962,620
Market cap861.865M
Beta (5Y monthly)0.51
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date09 Nov 2012
1y target estN/A
  • Motley Fool

    Can This COVID Vaccine Stock Help Make You Rich?

    There are a handful of companies that dominate the coronavirus vaccine market. Vaccine hesitancy prevents many people from getting inoculated. One company looking to make headway into the vaccine-hesitant crowd is Vaxart (NASDAQ: VXRT).

  • Motley Fool

    Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late?

    Vaxart (NASDAQ: VXRT) soared to stardom when its shares advanced 1,500% last year. The biotech company is developing a coronavirus-vaccine candidate in pill form. With 56% of Americans fully vaccinated, though, your question now may: Will Vaxart be too late to carve out market share?

  • Motley Fool

    These 2 COVID-19 Stocks Could Boost the Market Friday

    The stock market continued to gain ground on Thursday, picking up greater momentum as investors started to get more comfortable with the idea of a full economic recovery. A couple of stocks that have played instrumental roles with COVID posted big gains in after-hours trading on Thursday, and what they're saying about their businesses could have implications for the whole stock market. Below, we'll look at why Quidel (NASDAQ: QDEL) and Vaxart (NASDAQ: VXRT) moved sharply upward late Thursday afternoon.